Disease-modifying anti-rheumatic drugs

Bachmeier, Clarissa, Brooks, Peter M., Day, Richard O., Graham, Garry G., Littlejohn, Geoffrey O., Morand, Eric F., Pile, Kevin, and Williams, Kenneth M. (2005) Disease-modifying anti-rheumatic drugs. In: Nijkamp, Frans P., and Parnham, Michael J., (eds.) Principles of Immunopharmacology. Birkhäuser Basel, pp. 511-544.

[img]
Preview
Image (JPEG) (Book Cover) - Cover Image
Download (59kB)
[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

View at Publisher Website: http://dx.doi.org/10.1007/3-7643-7408-X_...
 
41


Abstract

[Extract] Rheumatoid arthritis is the most common inflammatory rheumatic disease, and has a prevalence of about 1% [1]. The total incidence of this disease is low but its burden is significant. Untreated, rheumatoid arthritis usually leads to join destruction, disability and increased mortality. Long-term management of patients is required, based not only on drug treatment, but also on non-pharmacological approaches such as physiotherapy and psychosocial support.

Item ID: 26656
Item Type: Book Chapter (Non-Research)
ISBN: 978-3-7643-5804-4
Keywords: anti-rheumatic drugs, pathophysiology
Date Deposited: 24 Apr 2013 06:24
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110322 Rheumatology and Arthritis @ 100%
SEO Codes: 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920116 Skeletal System and Disorders (incl. Arthritis) @ 100%
Downloads: Total: 41
Last 12 Months: 5
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page